Related Experiment Videos

Plasminogen activators, tissue degradation, and cancer

K Danø, P A Andreasen, J Grøndahl-Hansen

Advances in Cancer Research

|January 1, 1985

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nucleic acid aptamers against proteases.

Current medicinal chemistry·2011

Short sleep duration as a possible cause of obesity: critical analysis of the epidemiological evidence.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2010

Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice.

Journal of thrombosis and haemostasis : JTH·2007

Generation of antibodies to the urokinase receptor (uPAR) by DNA immunization of uPAR knockout mice: membrane-bound uPAR is not required for an antibody response.

Scandinavian journal of immunology·2003

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients.

British journal of cancer·2003

Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.

Biochemical Society transactions·2002

See all related articles